ReviewNeuropeptide FF, pain and analgesia
Introduction
Neuropeptide FF (NPFF, Phe–Leu–Phe–Gln–Pro–Gln–Arg–Phe–NH2) and the octadecapeptide neuropeptide AF (Ala–Gly–Glu–Gly–Leu–Ser–Ser–Pro–Phe–Trp–Ser–Leu–Ala–Ala–Pro–Gln–Arg–Phe–NH2) were isolated from bovine brain (Yang et al., 1985) using an antiserum directed against the molluscan peptide FMRFamide (Phe–Met–Arg–Phe–NH2; Price and Greenberg, 1977). Neuropeptide FF has been variously referred to as mammalian FMRFamide-like peptide, F8Famide or morphine modulating neuropeptide since neuropeptide FF like FMRFamide decreases the nociceptive threshold of rats (Yang et al., 1985). Invertebrate FMRFamide and small cardioactive peptides with an N-terminal Arg–Met-amide amino acid sequence exist in almost all molluscan species where they might function as neuromodulators or neurotransmitters. The amino acid sequence similarity between FMRFamide and the opioid peptide [Met5]enkephalin–Arg6–Phe7–amide pointed to possible structural and functional similarities in the two peptide families (Greenberg et al., 1983).
Neuropeptide FF together with cholecystokinin (CCK8-S, Asp–Tyr(SO3H)–Met–Gly–Trp–Met–Asp–Phe–NH2) or Tyr-MIF-1-like peptides (Tyr–Pro–Leu–Gly–NH2) are termed anti-opioid substances indicating that the morphine-induced changes in neuronal responses involve various non-opioid neurotransmitter networks that participate in an homeostatic system which acts to damp the effects of opioids. Accordingly, in addition to pain inhibiting pathways, there are anti-analgesic neuronal peptides which act by blocking pain inhibition in the central nervous system. The triggering of these systems readily explains the development of tolerance and dependence induced by chronic administration of opioids.
An anti-opioid model of tolerance and dependence (Rothman, 1992) postulates the existence of endogenous compounds that are able to reduce some of the acute (in particular antinociceptive) opioid effects, and permanently mask the effects of exogenous and endogenous opioids. Accordingly, chronic treatment with morphine should increase the release of anti-opioid peptides which, by stimulating specific receptors and specific networks, attenuate the pharmacological effects of morphine. As more opioid is given, more anti-opioid is released inducing tolerance to opioid effects. Following cessation of opioid administration, residual excess of anti-opioid is partly responsible for the withdrawal syndrome.
This model implies that anti-opioid peptides such as neuropeptide FF should be considered as tonic modulators of opioid functions. They therefore present an important target for new pharmacological agents able to modulate endogenous opioid function and amplify analgesic opioid effects. Agonists of the anti-opioid system are anticipated to block the analgesia produced by administration of opioids, whereas antagonists or antisera against anti-opioid peptides would potentiate analgesia.
Our knowledge of the neuropeptide FF system is now sufficiently advanced to describe (in broad terms) the role of neuropeptide FF peptides in the central control of opioid function.
Section snippets
Neuropeptide FF as a neurotransmitter/neuromodulator
Neuropeptide FF and neuropeptide AF were first isolated from bovine brain, and neuropeptide FF-like immunoreactivity was later demonstrated in the central nervous system of several mammals including humans (Panula et al., 1987; Majane et al., 1988; Kivipelto et al., 1989). Currently known peptide sequences of the neuropeptide FF family in various species are summarized in Table 1. A gene encoding both neuropeptide FF and neuropeptide AF has been reported in bovine, rat, mouse and human (Vilim
Anti-opioid effects of neuropeptide FF
The location of neuropeptide FF receptors in networks involved in pain modulation correlates well with the results of pharmacological experiments. Several studies have evidenced a role for neuropeptide FF in nociception and in the control of opioid functions and according to the anti-opioid model, neuropeptide FF produces hyperalgesia and inhibits opioid-induced analgesia.
Pro-opioid effects of neuropeptide FF
In contrast to pharmacological effects observed in rats and mice following supraspinal injection, other evidence has accumulated indicating that neuropeptide FF may display opioid-like effects dependent upon the animal model, injection route and pharmacological tests used. Thus, i.t. injections of neuropeptide FF or its analog (1DMe)Y8Famide produce a long-lasting analgesia in rats (Gouardères et al., 1993, Gouardères et al., 1996a). This analgesia is, however, opioid systems-dependent, since
Anti-opioid model and analgesia
The apparent contradiction between anti-opioid and analgesic effects of neuropeptide FF relates not only to spinal and supraspinal injection sites since, during the dark phase, neuropeptide FF can induce analgesia after i.c.v. injection (Oberling et al., 1993).
After i.c.v. injection in rats, the hyperesthesic effect of neuropeptide FF was followed, during nighttime, by a clear analgesic effect. The magnitude of the analgesic effect was observed to be dependent upon that of preceding
Conclusion
Neuropeptide FF constitutes a neuromodulatory neuronal system that is involved in the control of the transmission of nociceptive information. More precisely, neuropeptide FF appears to be a modulator of opioid antinociceptive function.
Neuropeptide FF has clear antiopioid effects, mostly at the supraspinal level. These have been demonstrated after i.c.v. injection, after microinfusion into particular brain nuclei and even at the level of the single isolated neuron. By reason of its antiopioid
Acknowledgements
We are particularly indebted to Dr J.C. Meunier for his critical comments and to Dr. C. Topham for correcting English style. Our research is supported by the Centre National de la Recherche Scientifique, the Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (97H004).
References (85)
- et al.
Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: A phaseolus vulgaris leucoagglutinin study
Neuroscience
(1995) - et al.
Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: A binding study
Brain Res.
(1989) - et al.
Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: Biochemical and immunocytochemical studies
Neuroscience
(1991) - et al.
Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system
Neuroscience
(1992) - et al.
Neuropeptide FF in the VTA blocks the analgesic effects of both intra-VTA morphine and exposure to stress
Brain Res.
(1997) - et al.
Dorsal raphe stimulation reduces responses of parafascicular neurons to noxious stimulation
Pain
(1983) - et al.
The antiopioid peptide, neuropeptide FF, enhances the effects of acute morphine on the cerebral monoamines in rats
Pharmacol. Res.
(1995) - et al.
Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression?
Trends Neurosci.
(1994) - et al.
Increases in arterial blood pressure in the rat in response to a new vertebrate neuropeptide, LPLRFamide, and a related molluscan peptide FMRFamide
Regul. Pept.
(1984) - et al.
Antiopioid activity of the cardioexcitatory peptide in central modulation of cardiovascular functions
Eur. J. Pharmacol.
(1986)
Serotoninergic projections from the midbrain periaqueductal gray and nucleus raphe dorsalis to the nucleus parafascicularis of the thalamus
Brain Res.
Differential modulation of μ- and δ-opioid antinociception by neuropeptide FF receptors in young mice
Neuropeptides
Glutamate via NMDA receptors promotes the release of NPFF, an anti-opioid peptide, from rat spinal cord slices
Regul. Pept.
Characterization of a potent agonist for NPFF receptors: Binding study in rat spinal cord membranes
Neuropharmacology
Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis
Regul. Pept.
Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the nucleus raphe dorsalis
Eur. J. Pharmacol.
Species differences in the localization of neuropeptide FF receptors in rodents and lagomorph brain and spinal cord
Peptides
A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia
Brain Res.
Neuropeptide FF receptors of mouse olfactory bulb: Binding properties and stimulation of adenylate cyclase activity
Peptides
Analogues of F8Famide resistant to degradation, with high affinity and in situ effects
Eur. J. Pharmacol.
Direct spinal pathways to the limbic system for nociceptive information
Trends Neurosci.
Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat
Eur. J. Pharmacol.
Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord
Neuroscience
Autoradiographic characterization of rat spinal neuropeptide FF receptors by using [][D.Tyr1, (NMe)Phe3]NPFF
Brain Res. Bull.
Electrophysiological effects of FLFQPQRFamide, an endogenous brain morphine modulating peptide, on cultured mouse spinal-cord neurons
Neuropeptides
On the central sites for the antinociceptive action of morphine and fentanyl
Neuropharmacology
Inhibitory influences of mammalian FMRFamide (Phe–Met–Arg–Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice
Neurosci. Lett.
Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia
Peptides
IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice
Peptides
Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain
Neuroscience
Neuropeptide FF is colocalized with catecholamine-synthesizing enzymes in neurons of the nucleus of the solitary tract
Neurosci. Lett.
Differential modulation of α2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF
Peptides
Neuropeptide FF in the rat spinal cord during carrageenan inflammation
Peptides
IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat
Neurosci. Lett.
Distribution of neuropeptide FF (FLFQPQRFamide) receptors in the adult rat spinal cord: Effects of dorsal rhizotomy and neonatal capsaicin
Neuroscience
Differential interactions of cholecystokinin and FLFQPQRF-NH2 with μ and δ opioid antinociception in the rat spinal cord
Neuropeptides
Biochemical characterization of FMRFNH2-like peptide in spinal cord of various mammalian species using specific radioimmunoassays
Peptides
Rat brain distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide
Brain Res.
FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat
Peptides
FMRF-NH2-like mammalian octapeptide: Possible role in opiate dependence and abstinence
Peptides
Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF
Peptides
Neuropeptide FLFQPQRFamide receptors within the ventral mesencephalon and dopaminergic terminal areas: Localization and functional antiopioid involvement
Neuroscience
Cited by (214)
Modulatory role of neuropeptide FF system in macrophages
2024, PeptidesBioanalytical method development and validation of MES207, a neuropeptide FF receptor antagonist, and its application in preclinical pharmacokinetics
2019, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences